Previous 10 | Next 10 |
IsoRay ( ISR +3.2% ) initiated with Buy rating and $1 (138% upside) price target at Dawson James. More news on: IsoRay, Inc., United Therapeutics Corporation, Dr. Reddy's Laboratories Limited, Healthcare stocks news, Stocks on the move, , Read more ...
RICHLAND, Wash., June 12, 2019 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that it will launch The Power of Blu™ camp...
Start Time: 16:30 End Time: 16:51 IsoRay, Inc. (ISR) Q3 2019 Earnings Conference Call May 09, 2019, 16:30 PM ET Company Participants Lori Woods - CEO Jonathan Hunt - CFO Mark Levin - IR Conference Call Participants Edward Woo - Ascendant Capital Presentation Oper...
IsoRay (NYSEMKT: ISR ): Q3 GAAP EPS of -$0.02 in-line. More news on: IsoRay, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Record Revenue and Gross Profit Revenue Increased 22% Year-Over-Year RICHLAND, Wash., May 09, 2019 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, toda...
RICHLAND, WASH., May 01, 2019 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discus...
RICHLAND, Wash., April 16, 2019 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, today announced a new training collaboration with Texas Oncology. The collaborat...
IsoRay, Inc. (ISR) Q2 2019 Earnings Conference Call February 12, 2019 04:30 PM ET Company Participants Mark Levin - IR Lori Woods - CEO Jonathan Hunt - CFO Conference Call Participants RK Swayampakula - H.C. Wainwright Presentation Operator Good day ladies and ge...
IsoRay (NYSEMKT: ISR ): Q2 GAAP EPS of -$0.02 beats by $0.01 . More news on: IsoRay, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Record Revenue and Gross Profit Revenue Increased 24% Year-Over-Year RICHLAND, Wash., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, tod...
News, Short Squeeze, Breakout and More Instantly...
IsoRay Inc. Company Name:
ISR Stock Symbol:
NYSE Market:
RICHLAND, Wash. and CORALVILLE, Iowa, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (formerly known as Isoray, Inc.) (NYSE AMERICAN: ISR), a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents and an innovator in seed b...
C omp any’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies New corporate tagline and website introduced N ew ticker symbol to be NYSE American: CATX RICHLAND,...
The combination delivers the promise of bringing powerful new perspectives to the rapidly emerging field of Alpha-Particle radiopharmaceuticals Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced the successful complet...